Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]

Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] was reported 115706 times

Drugs of the Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 SENSITISATION 159 0.2095
1 EJECTION FRACTION 117 0.2014
2 ENCEPHALITIS HERPES 92 0.1862
3 OPHTHALMIC HERPES SIMPLEX 81 0.1406
4 ENGRAFTMENT SYNDROME 76 0.1286
5 LIGHT CHAIN ANALYSIS INCREASED 128 0.1239
6 URINE LEUKOCYTE ESTERASE POSITIVE 79 0.1129
7 URINARY SEDIMENT PRESENT 66 0.1025
8 POLYCYSTIC OVARIES 159 0.1024
9 RED BLOOD CELLS URINE POSITIVE 98 0.1013
10 FUSARIUM INFECTION 69 0.0986
11 PLASMACYTOMA 155 0.0832
12 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 117 0.0828
13 PLASMA CELL MYELOMA RECURRENT 268 0.0824
14 MONOCLONAL IMMUNOGLOBULIN PRESENT 62 0.0816
15 VARICELLA ZOSTER VIRUS INFECTION 162 0.0781
16 ENCEPHALITIS VIRAL 93 0.0764
17 GRAFT VERSUS HOST DISEASE 548 0.0761
18 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 198 0.0716
19 ACUTE GRAFT VERSUS HOST DISEASE 320 0.0698
20 NEUTROPHIL PERCENTAGE INCREASED 87 0.0689
21 TOXOPLASMOSIS 73 0.0676
22 PLASMA CELL MYELOMA 2622 0.0671
23 LYMPHOCYTE PERCENTAGE DECREASED 90 0.0670
24 ENTEROCOCCAL BACTERAEMIA 70 0.0660
25 CYTOMEGALOVIRUS TEST POSITIVE 117 0.0656
26 GRAFT VERSUS HOST DISEASE IN SKIN 140 0.0635
27 STEM CELL TRANSPLANT 156 0.0624
28 EJECTION FRACTION ABNORMAL 76 0.0620
29 PARAINFLUENZAE VIRUS INFECTION 94 0.0617
30 SYSTEMIC MYCOSIS 72 0.0616
31 CYTOKINE RELEASE SYNDROME 1213 0.0604
32 PNEUMONIA CYTOMEGALOVIRAL 117 0.0602
33 HERPES SIMPLEX 378 0.0581
34 PLASMA CELL MYELOMA REFRACTORY 77 0.0575
35 CHRONIC GRAFT VERSUS HOST DISEASE 206 0.0570
36 WHITE BLOOD CELLS URINE POSITIVE 107 0.0568
37 CULTURE URINE POSITIVE 79 0.0562
38 ACUTE MYELOID LEUKAEMIA RECURRENT 119 0.0554
39 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 72 0.0547
40 FULL BLOOD COUNT DECREASED 1100 0.0545
41 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 115 0.0540
42 ASPERGILLOSIS 70 0.0536
43 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 317 0.0535
44 FULL BLOOD COUNT INCREASED 63 0.0529
45 NEPHRECTOMY 78 0.0525
46 CYTOMEGALOVIRUS INFECTION REACTIVATION 224 0.0507
47 SYSTEMIC CANDIDA 127 0.0505
48 CYTOMEGALOVIRUS VIRAEMIA 223 0.0501
49 PNEUMONIA FUNGAL 195 0.0494
50 HERPES OPHTHALMIC 65 0.0492
51 PSEUDOMONAL SEPSIS 84 0.0479
52 GENITAL HERPES 70 0.0457
53 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 232 0.0455
54 OBSTRUCTIVE SLEEP APNOEA SYNDROME 66 0.0452
55 MUCORMYCOSIS 117 0.0450
56 STENOTROPHOMONAS INFECTION 61 0.0450
57 HUMAN HERPESVIRUS 6 INFECTION 85 0.0449
58 EPSTEIN-BARR VIRUS INFECTION 280 0.0448
59 RHINITIS ALLERGIC 199 0.0447
60 CYTOMEGALOVIRUS CHORIORETINITIS 87 0.0446
61 BACTERIAL SEPSIS 145 0.0445
62 BONE MARROW TRANSPLANT 84 0.0443
63 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 114 0.0441
64 VENOOCCLUSIVE LIVER DISEASE 217 0.0439
65 HERPES VIRUS INFECTION 253 0.0439
66 POST HERPETIC NEURALGIA 63 0.0438
67 FEBRILE NEUTROPENIA 2837 0.0427
68 APLASTIC ANAEMIA 223 0.0427
69 CYTOMEGALOVIRUS INFECTION 703 0.0423
70 FUNGAEMIA 66 0.0419
71 CYSTITIS HAEMORRHAGIC 167 0.0414
72 LEUKAEMIA RECURRENT 70 0.0414
73 ENTEROCOCCAL INFECTION 200 0.0413
74 ESCHERICHIA BACTERAEMIA 97 0.0412
75 TOXIC ENCEPHALOPATHY 209 0.0412
76 NEUROTOXICITY 716 0.0408
77 NEUTROPHIL COUNT ABNORMAL 115 0.0407
78 OSTEOLYSIS 82 0.0401
79 BRONCHOPULMONARY ASPERGILLOSIS 311 0.0401
80 MULTIPLE MYELOMA 185 0.0397
81 VENOOCCLUSIVE DISEASE 99 0.0395
82 HYPOGAMMAGLOBULINAEMIA 259 0.0394
83 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 69 0.0390
84 ADENOVIRUS INFECTION 112 0.0386
85 BACTERIAL TEST POSITIVE 86 0.0385
86 URINE ABNORMALITY 175 0.0385
87 BONE LESION 136 0.0377
88 TUMOUR LYSIS SYNDROME 327 0.0371
89 URINE ANALYSIS ABNORMAL 111 0.0371
90 ENCEPHALITIS 254 0.0367
91 PNEUMONIA VIRAL 117 0.0367
92 STAPHYLOCOCCAL BACTERAEMIA 154 0.0354
93 CYTOPENIA 430 0.0351
94 NEUTROPENIC SEPSIS 238 0.0333
95 BLOOD IMMUNOGLOBULIN G DECREASED 81 0.0327
96 MUCOSAL INFLAMMATION 852 0.0325
97 ACUTE MYELOID LEUKAEMIA 507 0.0325
98 RHINOVIRUS INFECTION 126 0.0323
99 BACTERAEMIA 375 0.0316
100 NEUTROPHIL COUNT DECREASED 1274 0.0312
101 LYMPHOCYTE COUNT DECREASED 551 0.0311
102 CLOSTRIDIUM DIFFICILE COLITIS 328 0.0309
103 COVID-19 PNEUMONIA 364 0.0308
104 CHRONIC LYMPHOCYTIC LEUKAEMIA 146 0.0307
105 BK VIRUS INFECTION 103 0.0305
106 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 228 0.0304
107 WHITE BLOOD CELL COUNT DECREASED 3227 0.0297
108 ESCHERICHIA SEPSIS 86 0.0296
109 ACUTE LYMPHOCYTIC LEUKAEMIA 84 0.0296
110 NEUTROPENIC COLITIS 61 0.0295
111 PLATELET COUNT DECREASED 3102 0.0291
112 HYPERPARATHYROIDISM SECONDARY 72 0.0287
113 VARICELLA 68 0.0284
114 NEPHROGENIC ANAEMIA 130 0.0280
115 NEUROPATHY PERIPHERAL 2650 0.0278
116 LABORATORY TEST ABNORMAL 822 0.0278
117 STAPHYLOCOCCAL SEPSIS 137 0.0277
118 RED CELL DISTRIBUTION WIDTH INCREASED 115 0.0277
119 RESPIRATORY TRACT INFECTION VIRAL 64 0.0275
120 HOSPICE CARE 268 0.0271
121 PANCYTOPENIA 1498 0.0268
122 NEPHROPATHY TOXIC 298 0.0265
123 LACTOSE INTOLERANCE 66 0.0257
124 PROTEIN TOTAL INCREASED 68 0.0255
125 WHITE BLOOD CELL DISORDER 68 0.0254
126 ENCEPHALOPATHY 624 0.0254
127 MULTIPLE ORGAN DYSFUNCTION SYNDROME 718 0.0253
128 RESPIRATORY SYNCYTIAL VIRUS INFECTION 220 0.0252
129 HISTIOCYTOSIS HAEMATOPHAGIC 75 0.0252
130 RED BLOOD CELL COUNT DECREASED 718 0.0251
131 ASPERGILLUS INFECTION 161 0.0245
132 BLOOD TEST ABNORMAL 343 0.0244
133 BLOOD CULTURE POSITIVE 73 0.0244
134 HYPERBILIRUBINAEMIA 251 0.0242
135 FIBRIN D DIMER INCREASED 86 0.0242
136 KLEBSIELLA INFECTION 122 0.0241
137 NEUTROPENIA 3277 0.0241
138 PLEURITIC PAIN 66 0.0239
139 BONE MARROW DISORDER 72 0.0238
140 PATHOGEN RESISTANCE 214 0.0235
141 SEPTIC SHOCK 1017 0.0233
142 PROTEIN TOTAL DECREASED 88 0.0233
143 SQUAMOUS CELL CARCINOMA OF SKIN 141 0.0233
144 THROMBOTIC MICROANGIOPATHY 224 0.0230
145 ATELECTASIS 221 0.0228
146 RENAL TUBULAR DISORDER 64 0.0227
147 HYPERURICAEMIA 93 0.0226
148 FULL BLOOD COUNT ABNORMAL 238 0.0225
149 HERPES ZOSTER 1290 0.0224
150 LUNG INFILTRATION 198 0.0224
151 THROMBOCYTOPENIA 2483 0.0222
152 TOXIC EPIDERMAL NECROLYSIS 337 0.0222
153 DIFFUSE LARGE B-CELL LYMPHOMA 170 0.0220
154 PSEUDOMONAS INFECTION 188 0.0219
155 VITAMIN B12 DECREASED 63 0.0218
156 LYMPHOPENIA 307 0.0217
157 LUNG CONSOLIDATION 60 0.0214
158 PATHOLOGICAL FRACTURE 107 0.0211
159 PNEUMONIA BACTERIAL 191 0.0208
160 IMMUNE THROMBOCYTOPENIA 95 0.0207
161 BLOOD PHOSPHORUS DECREASED 75 0.0205
162 REBOUND ACID HYPERSECRETION 62 0.0205
163 PLATELET COUNT ABNORMAL 123 0.0203
164 HORDEOLUM 88 0.0203
165 IMMUNOSUPPRESSION 179 0.0203
166 SEPSIS 2254 0.0202
167 HAEMATOTOXICITY 192 0.0202
168 MULTIPLE ALLERGIES 158 0.0201
169 MULTIPLE-DRUG RESISTANCE 62 0.0200
170 RASH VESICULAR 96 0.0198
171 MENINGITIS ASEPTIC 89 0.0198
172 BLOOD CREATININE DECREASED 62 0.0198
173 ESCHERICHIA URINARY TRACT INFECTION 84 0.0197
174 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 75 0.0196
175 COMPRESSION FRACTURE 102 0.0190
176 ORAL HERPES 371 0.0190
177 BLOOD UREA INCREASED 318 0.0190
178 HAEMATOCRIT DECREASED 376 0.0189
179 FAILURE TO THRIVE 98 0.0189
180 SPLENOMEGALY 220 0.0188
181 SEASONAL ALLERGY 265 0.0187
182 ESCHERICHIA INFECTION 154 0.0187
183 MULTI-ORGAN FAILURE 323 0.0187
184 WHITE BLOOD CELL COUNT ABNORMAL 119 0.0186
185 PULMONARY THROMBOSIS 203 0.0186
186 APLASIA PURE RED CELL 64 0.0186
187 SERUM FERRITIN INCREASED 98 0.0186
188 TOOTH DISORDER 413 0.0186
189 HYPERCALCAEMIA 229 0.0185
190 RENAL FAILURE ACUTE 782 0.0184
191 AUTOIMMUNE HAEMOLYTIC ANAEMIA 63 0.0184
192 BLOOD BILIRUBIN INCREASED 491 0.0182
193 TRANSFUSION 190 0.0181
194 VASCULAR DEVICE INFECTION 82 0.0181
195 BLOOD LACTATE DEHYDROGENASE INCREASED 285 0.0180
196 LEUKAEMIA 169 0.0179
197 BLOOD ALBUMIN DECREASED 142 0.0179
198 ENTEROCOLITIS 103 0.0178
199 ATRIAL FLUTTER 142 0.0178
200 CARPAL TUNNEL SYNDROME 249 0.0178
201 DISSEMINATED INTRAVASCULAR COAGULATION 250 0.0177
202 PNEUMONIA 5701 0.0176
203 DRUG RESISTANCE 447 0.0174
204 PNEUMOCYSTIS JIROVECII PNEUMONIA 174 0.0173
205 HYPOALBUMINAEMIA 134 0.0172
206 CLOSTRIDIUM DIFFICILE INFECTION 376 0.0172
207 HYPOPHOSPHATAEMIA 127 0.0172
208 BLOOD CALCIUM DECREASED 193 0.0171
209 TASTE DISORDER 348 0.0171
210 MYELODYSPLASTIC SYNDROME 248 0.0171
211 HYPOXIA 600 0.0170
212 BLOOD POTASSIUM DECREASED 510 0.0169
213 BLOOD CREATININE INCREASED 1105 0.0169
214 MENINGITIS 113 0.0169
215 ACUTE KIDNEY INJURY 2573 0.0168
216 ACUTE RESPIRATORY FAILURE 323 0.0168
217 RENAL TUBULAR NECROSIS 164 0.0167
218 CANDIDA INFECTION 281 0.0166
219 HYPERVOLAEMIA 82 0.0166
220 SPINAL COMPRESSION FRACTURE 137 0.0166
221 MONOCYTE COUNT INCREASED 60 0.0165
222 BACTERIAL INFECTION 307 0.0164
223 BLOOD MAGNESIUM DECREASED 142 0.0164
224 HAEMODIALYSIS 138 0.0164
225 SPINAL OSTEOARTHRITIS 143 0.0163
226 IMMUNODEFICIENCY 242 0.0162
227 VIRAL UPPER RESPIRATORY TRACT INFECTION 77 0.0162
228 THROMBOSIS 1303 0.0162
229 DEEP VEIN THROMBOSIS 1048 0.0161
230 HAEMOGLOBIN DECREASED 1651 0.0161
231 ACUTE RESPIRATORY DISTRESS SYNDROME 282 0.0159
232 HYPOKALAEMIA 733 0.0159
233 RASH MACULO-PAPULAR 353 0.0159
234 CATHETER SITE INFECTION 60 0.0158
235 MENTAL STATUS CHANGES 439 0.0158
236 ORTHOSTATIC HYPOTENSION 275 0.0158
237 STATUS EPILEPTICUS 178 0.0157
238 CANDIDIASIS 63 0.0157
239 AGEUSIA 390 0.0156
240 INCREASED TENDENCY TO BRUISE 143 0.0155
241 BODY HEIGHT DECREASED 166 0.0155
242 BENIGN PROSTATIC HYPERPLASIA 80 0.0155
243 PERIPHERAL SENSORY NEUROPATHY 90 0.0154
244 FEBRILE BONE MARROW APLASIA 65 0.0153
245 STAPHYLOCOCCAL INFECTION 504 0.0153
246 PERFORMANCE STATUS DECREASED 71 0.0152
247 TRANSPLANT REJECTION 120 0.0150
248 BLOOD COUNT ABNORMAL 227 0.0150
249 HICCUPS 122 0.0148
250 PROTEIN URINE PRESENT 74 0.0148
251 PULMONARY ALVEOLAR HAEMORRHAGE 83 0.0148
252 RESPIRATORY FAILURE 1077 0.0148
253 MUSCULOSKELETAL CHEST PAIN 228 0.0147
254 RENAL DISORDER 682 0.0146
255 SKIN ABRASION 69 0.0146
256 BONE MARROW FAILURE 294 0.0145
257 ORAL DISORDER 106 0.0144
258 PYREXIA 4990 0.0144
259 UPPER RESPIRATORY TRACT INFECTION 665 0.0144
260 BLOOD URIC ACID INCREASED 83 0.0144
261 LEFT VENTRICULAR HYPERTROPHY 61 0.0142
262 DERMATITIS BULLOUS 103 0.0142
263 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 110 0.0141
264 HAEMOGLOBIN ABNORMAL 91 0.0141
265 PARTIAL SEIZURES 74 0.0141
266 PETECHIAE 147 0.0141
267 STREPTOCOCCAL INFECTION 78 0.0140
268 BLOOD CREATINE INCREASED 62 0.0140
269 ALTERED STATE OF CONSCIOUSNESS 302 0.0139
270 HYPERNATRAEMIA 69 0.0138
271 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 356 0.0138
272 NEPHROPATHY 128 0.0137
273 CONSTIPATION 2989 0.0137
274 SLEEP APNOEA SYNDROME 261 0.0137
275 ANAEMIA 2607 0.0137
276 SINUS TACHYCARDIA 194 0.0136
277 LEUKOPENIA 683 0.0136
278 PLEURAL EFFUSION 827 0.0136
279 GINGIVITIS 73 0.0135
280 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 111 0.0134
281 OSTEOPENIA 204 0.0134
282 ATRIAL FIBRILLATION 1309 0.0134
283 RALES 78 0.0134
284 RENAL FAILURE 1774 0.0133
285 OLIGURIA 82 0.0132
286 BLOOD THYROID STIMULATING HORMONE DECREASED 60 0.0132
287 IMMUNE SYSTEM DISORDER 174 0.0132
288 INFUSION SITE EXTRAVASATION 82 0.0132
289 PULMONARY HAEMORRHAGE 103 0.0132
290 LUMBAR VERTEBRAL FRACTURE 60 0.0131
291 TACHYPNOEA 178 0.0131
292 ODYNOPHAGIA 78 0.0131
293 PERICARDIAL EFFUSION 301 0.0130
294 ECCHYMOSIS 89 0.0130
295 CELLULITIS 654 0.0130
296 HEPATITIS B 78 0.0129
297 ASPARTATE AMINOTRANSFERASE INCREASED 685 0.0129
298 VITAMIN D DECREASED 110 0.0129
299 POLYNEUROPATHY 154 0.0128
300 C-REACTIVE PROTEIN INCREASED 467 0.0128
301 END STAGE RENAL DISEASE 233 0.0128
302 ORAL CANDIDIASIS 167 0.0127
303 HYPOMAGNESAEMIA 176 0.0126
304 ALANINE AMINOTRANSFERASE INCREASED 775 0.0126
305 DEVICE RELATED INFECTION 193 0.0125
306 RENAL IMPAIRMENT 1053 0.0125
307 SPINAL FRACTURE 251 0.0125
308 BLOOD URINE PRESENT 236 0.0124
309 BLOOD ALKALINE PHOSPHATASE INCREASED 308 0.0124
310 STOMATITIS 751 0.0124
311 HYDRONEPHROSIS 92 0.0123
312 SKIN LESION 337 0.0123
313 RESPIRATORY TRACT INFECTION 319 0.0122
314 URINE OUTPUT DECREASED 107 0.0122
315 HYPOTHYROIDISM 390 0.0122
316 PAPULE 86 0.0122
317 SINUS BRADYCARDIA 117 0.0121
318 HYPERTRANSAMINASAEMIA 84 0.0121
319 FUNGAL INFECTION 402 0.0120
320 GASTROINTESTINAL INFECTION 108 0.0120
321 NECROSIS 67 0.0120
322 BODY TEMPERATURE INCREASED 245 0.0120
323 BASAL CELL CARCINOMA 187 0.0120
324 TOOTH INFECTION 158 0.0120
325 MALNUTRITION 134 0.0120
326 LUNG INFECTION 185 0.0119
327 HAEMORRHAGE INTRACRANIAL 178 0.0119
328 CHRONIC KIDNEY DISEASE 901 0.0118
329 GENERALISED OEDEMA 145 0.0117
330 RASH PRURITIC 633 0.0117
331 BLOOD SODIUM DECREASED 220 0.0117
332 DRUG LEVEL INCREASED 193 0.0116
333 INFECTION 1683 0.0116
334 SUBDURAL HAEMATOMA 166 0.0116
335 PNEUMONITIS 315 0.0116
336 DIARRHOEA 7440 0.0115
337 PULMONARY OEDEMA 514 0.0115
338 LYMPHADENOPATHY 406 0.0115
339 SINUS DISORDER 226 0.0114
340 HEPATIC CYTOLYSIS 145 0.0114
341 INTERVERTEBRAL DISC DEGENERATION 105 0.0113
342 RESPIRATORY DISTRESS 313 0.0113
343 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 192 0.0113
344 ENTERITIS 72 0.0112
345 VIRAL INFECTION 374 0.0112
346 HEPATOMEGALY 110 0.0112
347 BLOOD CALCIUM INCREASED 98 0.0112
348 ACIDOSIS 85 0.0111
349 RIB FRACTURE 228 0.0111
350 PULMONARY MASS 165 0.0111
351 BACK DISORDER 180 0.0111
352 GAMMA-GLUTAMYLTRANSFERASE INCREASED 245 0.0110
353 DIVERTICULITIS 306 0.0110
354 ANURIA 95 0.0110
355 STEVENS-JOHNSON SYNDROME 245 0.0110
356 CARDIAC FAILURE ACUTE 73 0.0109
357 HYPOCALCAEMIA 207 0.0109
358 GOUT 196 0.0109
359 DISEASE PROGRESSION 1290 0.0109
360 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 104 0.0109
361 DEHYDRATION 1452 0.0109
362 BRAIN OEDEMA 137 0.0108
363 TRICUSPID VALVE INCOMPETENCE 86 0.0108
364 HEPATOTOXICITY 241 0.0108
365 INFUSION SITE SWELLING 68 0.0108
366 EYE INFECTION 122 0.0108
367 WHITE BLOOD CELL COUNT INCREASED 413 0.0108
368 ONYCHOCLASIS 74 0.0107
369 HAEMOLYSIS 83 0.0107
370 CORONAVIRUS INFECTION 71 0.0107
371 MITRAL VALVE INCOMPETENCE 121 0.0107
372 HYPOPHAGIA 273 0.0107
373 LEUKOCYTOSIS 193 0.0107
374 SPINAL DISORDER 101 0.0107
375 PERONEAL NERVE PALSY 60 0.0105
376 GINGIVAL PAIN 84 0.0105
377 COVID-19 1848 0.0105
378 HYPERLIPIDAEMIA 125 0.0104
379 TUBULOINTERSTITIAL NEPHRITIS 196 0.0104
380 SUPRAVENTRICULAR TACHYCARDIA 100 0.0104
381 DECUBITUS ULCER 85 0.0104
382 FATIGUE 8121 0.0104
383 BRONCHITIS 772 0.0104
384 ELECTROLYTE IMBALANCE 121 0.0104
385 SINUSITIS 1063 0.0104
386 PULMONARY EMBOLISM 983 0.0103
387 TRANSAMINASES INCREASED 230 0.0103
388 PERIPHERAL SWELLING 1593 0.0103
389 BONE DISORDER 188 0.0103
390 INFLUENZA 1150 0.0103
391 TOOTH ABSCESS 105 0.0103
392 UROSEPSIS 95 0.0103
393 PURPURA 91 0.0103
394 RENAL FAILURE CHRONIC 79 0.0103
395 PROCTALGIA 66 0.0103
396 NEURALGIA 249 0.0102
397 BONE PAIN 599 0.0102
398 OSTEOMYELITIS 185 0.0102
399 MUSCLE SPASMS 1869 0.0102
400 TENDERNESS 106 0.0102
401 HYPERGLYCAEMIA 368 0.0101
402 CATARACT 600 0.0101
403 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 103 0.0100
404 HEPATITIS ACUTE 65 0.0100
405 OESOPHAGITIS 109 0.0100
406 ORAL PAIN 223 0.0099
407 DECREASED APPETITE 2306 0.0099
408 SARS-COV-2 TEST POSITIVE 131 0.0099
409 RASH 4318 0.0099
410 MYOCLONUS 118 0.0099
411 NEUTROPHIL COUNT INCREASED 101 0.0099
412 ATAXIA 117 0.0098
413 AGRANULOCYTOSIS 183 0.0098
414 URINARY TRACT INFECTION 1677 0.0098
415 LARGE INTESTINE POLYP 68 0.0098
416 COLITIS 372 0.0098
417 CARDIOMEGALY 120 0.0097
418 LEFT VENTRICULAR DYSFUNCTION 65 0.0097
419 BRAIN FOG 152 0.0097
420 RENAL CYST 77 0.0097
421 MOUTH HAEMORRHAGE 71 0.0097
422 SMALL INTESTINAL OBSTRUCTION 119 0.0097
423 OEDEMA 524 0.0097
424 ILEUS 120 0.0096
425 THERAPY PARTIAL RESPONDER 150 0.0096
426 HAEMOLYTIC ANAEMIA 86 0.0096
427 DIZZINESS POSTURAL 93 0.0096
428 HAEMODYNAMIC INSTABILITY 73 0.0096
429 DRUG TOXICITY 130 0.0095
430 SKIN INFECTION 107 0.0095
431 VITAMIN D DEFICIENCY 93 0.0095
432 CONFUSIONAL STATE 1541 0.0095
433 ASCITES 280 0.0095
434 GASTROENTERITIS 139 0.0095
435 FACIAL PAIN 85 0.0095
436 FACIAL PARALYSIS 81 0.0095
437 HEPATIC FAILURE 286 0.0095
438 NERVOUS SYSTEM DISORDER 296 0.0095
439 LOCALISED INFECTION 229 0.0095
440 HYPONATRAEMIA 533 0.0095
441 DIVERTICULUM 67 0.0094
442 OEDEMA PERIPHERAL 1149 0.0094
443 GASTROOESOPHAGEAL REFLUX DISEASE 756 0.0094
444 PRODUCT DISTRIBUTION ISSUE 87 0.0094
445 HYPOTENSION 1873 0.0093
446 TOXIC SKIN ERUPTION 94 0.0093
447 HAEMOPTYSIS 259 0.0093
448 CHILLS 1084 0.0092
449 GALLBLADDER DISORDER 165 0.0092
450 LIVER FUNCTION TEST ABNORMAL 268 0.0092
451 APHASIA 278 0.0092
452 PHARYNGITIS 114 0.0092
453 NIGHT SWEATS 295 0.0091
454 EMBOLISM 76 0.0091
455 DEPRESSED LEVEL OF CONSCIOUSNESS 362 0.0091
456 DRUG ERUPTION 162 0.0091
457 SECOND PRIMARY MALIGNANCY 76 0.0091
458 DENTAL CARIES 101 0.0091
459 SCAB 104 0.0091
460 PROTEINURIA 173 0.0091
461 DELIRIUM 315 0.0091
462 DERMATITIS ALLERGIC 114 0.0091
463 CHOLESTASIS 174 0.0091
464 ANHEDONIA 238 0.0090
465 FIBROMYALGIA 219 0.0090
466 RESPIRATORY TRACT CONGESTION 143 0.0090
467 PHOTOPHOBIA 169 0.0090
468 UPPER-AIRWAY COUGH SYNDROME 74 0.0090
469 ASTHENIA 3372 0.0090
470 DERMATITIS CONTACT 102 0.0089
471 VASCULITIS 104 0.0089
472 HAEMORRHOIDS 174 0.0089
473 NEPHROTIC SYNDROME 61 0.0089
474 CHOLECYSTITIS 106 0.0089
475 TOOTHACHE 161 0.0089
476 WEIGHT FLUCTUATION 93 0.0089
477 HYPOAESTHESIA 1329 0.0089
478 BLOOD POTASSIUM INCREASED 144 0.0089
479 SKIN DISCOLOURATION 406 0.0088
480 COAGULOPATHY 147 0.0088
481 GINGIVAL BLEEDING 120 0.0088
482 ARTHROPOD BITE 65 0.0088
483 MOUTH ULCERATION 184 0.0087
484 DISORIENTATION 346 0.0087
485 MASS 122 0.0087
486 FLUID OVERLOAD 127 0.0087
487 ERYTHEMA MULTIFORME 81 0.0087
488 LYMPHOMA 134 0.0087
489 HALLUCINATION, VISUAL 183 0.0087
490 PRODUCT ADMINISTRATION INTERRUPTED 68 0.0087
491 ECONOMIC PROBLEM 131 0.0086
492 LARGE INTESTINE PERFORATION 60 0.0086
493 EOSINOPHIL COUNT INCREASED 72 0.0086
494 NERVE INJURY 96 0.0086
495 DYSPNOEA EXERTIONAL 325 0.0086
496 LIPASE INCREASED 66 0.0086
497 FLUID RETENTION 438 0.0086
498 SQUAMOUS CELL CARCINOMA 81 0.0086
499 VENTRICULAR EXTRASYSTOLES 89 0.0086
500 INFUSION SITE PAIN 110 0.0085
501 PERIPHERAL COLDNESS 117 0.0085
502 LIVER DISORDER 377 0.0085
503 HYPOAESTHESIA ORAL 128 0.0085
504 MUSCLE STRAIN 73 0.0084
505 FLANK PAIN 79 0.0084
506 ADVERSE DRUG REACTION 755 0.0084
507 EPISTAXIS 628 0.0084
508 SPINAL PAIN 98 0.0084
509 FURUNCLE 66 0.0083
510 HAEMATURIA 285 0.0083
511 LIMB DISCOMFORT 257 0.0083
512 ARTERIOSCLEROSIS 78 0.0083
513 NASOPHARYNGITIS 1526 0.0083
514 SKIN LACERATION 90 0.0083
515 BLOOD IRON DECREASED 98 0.0083
516 RASH GENERALISED 213 0.0082
517 MYOPATHY 71 0.0082
518 HIP FRACTURE 264 0.0082
519 TACHYCARDIA 726 0.0082
520 GASTRITIS 215 0.0082
521 TORSADE DE POINTES 64 0.0081
522 BACK PAIN 1894 0.0081
523 GASTROENTERITIS VIRAL 147 0.0081
524 DIARRHOEA HAEMORRHAGIC 76 0.0081
525 APHTHOUS ULCER 63 0.0081
526 EXOSTOSIS 74 0.0081
527 CYSTITIS 258 0.0081
528 UNEVALUABLE EVENT 613 0.0081
529 ROTATOR CUFF SYNDROME 104 0.0081
530 CONJUNCTIVITIS 150 0.0081
531 OSTEONECROSIS OF JAW 200 0.0081
532 DYSARTHRIA 304 0.0081
533 NOCTURIA 98 0.0081
534 GLOMERULAR FILTRATION RATE DECREASED 99 0.0080
535 GENERALISED TONIC-CLONIC SEIZURE 133 0.0080
536 HEPATIC FUNCTION ABNORMAL 298 0.0080
537 CONTUSION 768 0.0080
538 HYPERKALAEMIA 279 0.0079
539 NO THERAPEUTIC RESPONSE 97 0.0079
540 RASH MACULAR 277 0.0079
541 LIVER FUNCTION TEST INCREASED 170 0.0079
542 SKIN CANCER 170 0.0079
543 EAR DISCOMFORT 81 0.0079
544 CHROMATURIA 178 0.0079
545 PNEUMOTHORAX 125 0.0079
546 BLOOD DISORDER 63 0.0079
547 FEELING COLD 217 0.0078
548 SKIN DISORDER 259 0.0078
549 RASH PAPULAR 174 0.0078
550 ACUTE HEPATIC FAILURE 106 0.0077
551 SUBARACHNOID HAEMORRHAGE 79 0.0077
552 CARDIAC MURMUR 67 0.0077
553 PULMONARY CONGESTION 102 0.0077
554 THERAPY NON-RESPONDER 347 0.0077
555 DRY EYE 385 0.0077
556 TOOTH FRACTURE 85 0.0077
557 EYE PAIN 435 0.0077
558 PNEUMONIA ASPIRATION 192 0.0077
559 PAIN IN JAW 217 0.0077
560 BRADYCARDIA 405 0.0076
561 BALANCE DISORDER 660 0.0076
562 SKIN ULCER 197 0.0076
563 EJECTION FRACTION DECREASED 118 0.0076
564 RESPIRATORY DISORDER 227 0.0076
565 LIMB INJURY 206 0.0076
566 CENTRAL NERVOUS SYSTEM LESION 104 0.0076
567 PRODUCTIVE COUGH 360 0.0075
568 COGNITIVE DISORDER 352 0.0075
569 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 362 0.0075
570 RHINORRHOEA 485 0.0075
571 APPENDICITIS 70 0.0075
572 COUGH 2097 0.0075
573 OROPHARYNGEAL PAIN 691 0.0075
574 MUSCULAR WEAKNESS 844 0.0074
575 WOUND INFECTION 81 0.0074
576 SWELLING FACE 480 0.0074
577 LOWER RESPIRATORY TRACT INFECTION 335 0.0074
578 GRAND MAL CONVULSION 68 0.0074
579 INFUSION RELATED REACTION 488 0.0074
580 BLADDER DISORDER 73 0.0073
581 CEREBRAL HAEMORRHAGE 263 0.0073
582 SYNCOPE 735 0.0073
583 TREMOR 1218 0.0073
584 OFF LABEL USE 6422 0.0073
585 CARDIAC DISORDER 686 0.0073
586 EYE DISCHARGE 76 0.0073
587 RENAL INJURY 217 0.0073
588 BLOOD THYROID STIMULATING HORMONE INCREASED 67 0.0073
589 BLISTER 408 0.0073
590 IRON DEFICIENCY ANAEMIA 67 0.0073
591 DYSURIA 267 0.0072
592 SINUS CONGESTION 98 0.0072
593 HEPATIC STEATOSIS 135 0.0072
594 INTERVERTEBRAL DISC PROTRUSION 158 0.0072
595 EAR PAIN 140 0.0072
596 DYSGEUSIA 533 0.0072
597 FOOT FRACTURE 136 0.0072
598 OSTEOPOROSIS 295 0.0072
599 NAUSEA 5670 0.0072
600 VENTRICULAR TACHYCARDIA 118 0.0071
601 POLLAKIURIA 298 0.0071
602 BLOOD PRESSURE ABNORMAL 142 0.0071
603 HEART RATE DECREASED 250 0.0071
604 DIALYSIS 101 0.0071
605 EAR INFECTION 189 0.0071
606 HYPERSOMNIA 203 0.0071
607 PLATELET COUNT INCREASED 92 0.0070
608 ARTHROPATHY 392 0.0070
609 PYELONEPHRITIS 61 0.0070
610 SCIATICA 112 0.0070
611 EOSINOPHILIA 123 0.0070
612 HEPATIC ENZYME INCREASED 478 0.0070
613 PARAESTHESIA 1103 0.0070
614 NECK PAIN 391 0.0070
615 HEPATITIS 179 0.0070
616 LIGAMENT SPRAIN 69 0.0070
617 FALL 2317 0.0070
618 HYPERCHOLESTEROLAEMIA 67 0.0069
619 DECREASED IMMUNE RESPONSIVENESS 68 0.0069
620 LETHARGY 398 0.0069
621 RASH ERYTHEMATOUS 330 0.0069
622 TRANSIENT ISCHAEMIC ATTACK 232 0.0069
623 CARDIAC FAILURE 547 0.0068
624 NEOPLASM 78 0.0068
625 FACE OEDEMA 114 0.0068
626 URINARY RETENTION 225 0.0067
627 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 351 0.0067
628 NERVE COMPRESSION 62 0.0067
629 FEEDING DISORDER 136 0.0067
630 LACERATION 63 0.0067
631 NEPHROLITHIASIS 305 0.0066
632 GASTRIC DISORDER 228 0.0066
633 CARDIAC FAILURE CONGESTIVE 533 0.0066
634 HERNIA 128 0.0066
635 THYROID DISORDER 102 0.0066
636 WEIGHT DECREASED 1842 0.0066
637 POOR QUALITY SLEEP 142 0.0066
638 ADRENAL INSUFFICIENCY 80 0.0066
639 INTESTINAL PERFORATION 74 0.0066
640 OCULAR DISCOMFORT 74 0.0066
641 DRUG LEVEL DECREASED 67 0.0066
642 OSTEOARTHRITIS 279 0.0066
643 MUSCULOSKELETAL DISORDER 125 0.0066
644 CARDIOMYOPATHY 97 0.0066
645 EYE SWELLING 244 0.0066
646 HEART RATE IRREGULAR 148 0.0065
647 ABDOMINAL DISTENSION 683 0.0065
648 EMPHYSEMA 66 0.0065
649 PULMONARY HYPERTENSION 136 0.0065
650 INCONTINENCE 69 0.0065
651 ANOREXIA 84 0.0065
652 URINARY INCONTINENCE 193 0.0065
653 BURNING SENSATION 456 0.0065
654 DECREASED ACTIVITY 70 0.0065
655 UPPER LIMB FRACTURE 129 0.0065
656 POOR VENOUS ACCESS 67 0.0065
657 DIPLOPIA 168 0.0065
658 CYST 80 0.0064
659 JAUNDICE 173 0.0064
660 PRODUCT DOSE OMISSION 419 0.0064
661 UNRESPONSIVE TO STIMULI 165 0.0064
662 EATING DISORDER 136 0.0064
663 DYSPNOEA 3615 0.0064
664 INSOMNIA 1699 0.0064
665 HYPERTENSION 1351 0.0064
666 HEMIPARESIS 108 0.0064
667 DYSPHAGIA 605 0.0064
668 CHOLELITHIASIS 209 0.0064
669 DISEASE RECURRENCE 303 0.0064
670 SHOCK 146 0.0063
671 HAEMATOMA 164 0.0063
672 PANCREATITIS ACUTE 142 0.0063
673 OXYGEN SATURATION DECREASED 355 0.0063
674 PRESYNCOPE 153 0.0063
675 VOMITING 2953 0.0063
676 DYSPEPSIA 617 0.0063
677 GASTROINTESTINAL DISORDER 561 0.0063
678 CORONARY ARTERY DISEASE 189 0.0062
679 SWELLING 583 0.0062
680 BLOOD TRIGLYCERIDES INCREASED 110 0.0062
681 LUNG DISORDER 305 0.0062
682 CHEST DISCOMFORT 637 0.0062
683 ANKLE FRACTURE 96 0.0062
684 DYSPHONIA 362 0.0062
685 DRUG-INDUCED LIVER INJURY 194 0.0062
686 WHEEZING 366 0.0062
687 ABDOMINAL PAIN 1426 0.0061
688 VISION BLURRED 840 0.0061
689 ABDOMINAL DISCOMFORT 1022 0.0061
690 APHONIA 85 0.0061
691 CHEST PAIN 1120 0.0060
692 METABOLIC ACIDOSIS 193 0.0060
693 LACRIMATION INCREASED 182 0.0060
694 ABSCESS 96 0.0060
695 BURSITIS 73 0.0060
696 GENERAL PHYSICAL HEALTH DETERIORATION 696 0.0060
697 DEAFNESS 157 0.0060
698 UPPER GASTROINTESTINAL HAEMORRHAGE 101 0.0060
699 MOTOR DYSFUNCTION 61 0.0060
700 FLATULENCE 339 0.0060
701 GLAUCOMA 115 0.0060
702 PARAESTHESIA ORAL 86 0.0060
703 THERAPY INTERRUPTED 425 0.0059
704 AMNESIA 386 0.0059
705 MYOCARDITIS 68 0.0059
706 HAEMATEMESIS 150 0.0059
707 GASTRIC ULCER 112 0.0059
708 EYE DISORDER 193 0.0059
709 MICTURITION URGENCY 67 0.0059
710 KIDNEY INFECTION 115 0.0059
711 FAECES DISCOLOURED 127 0.0059
712 DYSSTASIA 171 0.0059
713 CARDIAC ARREST 482 0.0058
714 MUSCLE TIGHTNESS 94 0.0058
715 DIZZINESS 2886 0.0058
716 INTERSTITIAL LUNG DISEASE 280 0.0058
717 VERTIGO 352 0.0058
718 AGITATION 424 0.0058
719 DRUG INTOLERANCE 556 0.0058
720 MALIGNANT MELANOMA 77 0.0057
721 COORDINATION ABNORMAL 80 0.0057
722 PRODUCT DOSE OMISSION ISSUE 1683 0.0057
723 DEATH 4930 0.0057
724 PRURITUS 2194 0.0057
725 MACULAR DEGENERATION 68 0.0057
726 ILLNESS 585 0.0057
727 SCAR 97 0.0057
728 RESTLESS LEGS SYNDROME 103 0.0057
729 DRY MOUTH 459 0.0057
730 JOINT SWELLING 680 0.0056
731 SPEECH DISORDER 295 0.0056
732 WOUND 157 0.0056
733 FEELING JITTERY 107 0.0056
734 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 308 0.0056
735 MUSCLE ATROPHY 71 0.0056
736 ABDOMINAL PAIN UPPER 1150 0.0056
737 SKIN EXFOLIATION 471 0.0056
738 RESTLESSNESS 204 0.0056
739 OSTEONECROSIS 183 0.0056
740 HALLUCINATION 419 0.0056
741 DRUG INTERACTION 882 0.0056
742 SENSORY DISTURBANCE 89 0.0055
743 EYE HAEMORRHAGE 74 0.0055
744 IMPAIRED HEALING 182 0.0055
745 MEMORY IMPAIRMENT 761 0.0055
746 BRONCHOSPASM 79 0.0055
747 NEOPLASM PROGRESSION 191 0.0055
748 GAIT DISTURBANCE 1044 0.0054
749 QUALITY OF LIFE DECREASED 73 0.0054
750 HEAD INJURY 172 0.0054
751 HIATUS HERNIA 70 0.0054
752 TINNITUS 248 0.0054
753 ELECTROCARDIOGRAM QT PROLONGED 194 0.0054
754 JOINT RANGE OF MOTION DECREASED 72 0.0054
755 PSYCHOMOTOR HYPERACTIVITY 89 0.0054
756 MUSCULOSKELETAL DISCOMFORT 92 0.0053
757 HEART RATE INCREASED 529 0.0053
758 NASAL CONGESTION 313 0.0053
759 ANOSMIA 77 0.0053
760 HEADACHE 3325 0.0053
761 HOSPITALISATION 808 0.0053
762 PARALYSIS 75 0.0052
763 FEELING HOT 321 0.0052
764 INSURANCE ISSUE 80 0.0052
765 COMA 248 0.0052
766 PHOTOSENSITIVITY REACTION 86 0.0052
767 DRY SKIN 694 0.0052
768 BLOOD PRESSURE DECREASED 343 0.0052
769 GAIT INABILITY 172 0.0051
770 HAEMATOCHEZIA 284 0.0051
771 ABDOMINAL PAIN LOWER 130 0.0051
772 BONE DENSITY DECREASED 161 0.0051
773 MYELOSUPPRESSION 185 0.0051
774 MELAENA 113 0.0051
775 GASTROINTESTINAL HAEMORRHAGE 429 0.0051
776 CEREBRAL INFARCTION 125 0.0051
777 PAIN IN EXTREMITY 1507 0.0051
778 CONVULSION 292 0.0051
779 SOMNOLENCE 1028 0.0051
780 CONDITION AGGRAVATED 1552 0.0051
781 ACUTE MYOCARDIAL INFARCTION 150 0.0051
782 INCREASED APPETITE 97 0.0051
783 LIP SWELLING 169 0.0051
784 ARRHYTHMIA 240 0.0051
785 LOSS OF CONSCIOUSNESS 649 0.0051
786 URTICARIA 845 0.0050
787 SKIN REACTION 71 0.0050
788 FEMUR FRACTURE 155 0.0050
789 BLOOD CHOLESTEROL INCREASED 233 0.0050
790 MYALGIA 849 0.0050
791 MULTIPLE FRACTURES 82 0.0050
792 PRODUCT DOSE OMISSION IN ERROR 141 0.0050
793 HEAD DISCOMFORT 88 0.0050
794 CARDIO-RESPIRATORY ARREST 207 0.0049
795 WEIGHT INCREASED 1107 0.0049
796 INFLAMMATION 255 0.0049
797 HAIR TEXTURE ABNORMAL 66 0.0049
798 INTENTIONAL PRODUCT USE ISSUE 430 0.0049
799 BLOOD PRESSURE INCREASED 749 0.0049
800 MUSCULOSKELETAL PAIN 256 0.0049
801 MENTAL IMPAIRMENT 118 0.0049
802 SKIN HAEMORRHAGE 72 0.0049
803 SEIZURE 557 0.0048
804 BLOOD PRESSURE SYSTOLIC INCREASED 94 0.0048
805 ERYTHEMA 988 0.0048
806 INTERNATIONAL NORMALISED RATIO INCREASED 137 0.0048
807 RECTAL HAEMORRHAGE 206 0.0048
808 MALAISE 2100 0.0048
809 PAIN 2936 0.0048
810 ULCER 76 0.0048
811 DERMATITIS 100 0.0048
812 INTESTINAL OBSTRUCTION 179 0.0047
813 FEELING ABNORMAL 1137 0.0047
814 ANXIETY 1334 0.0047
815 PRODUCT PRESCRIBING ISSUE 102 0.0047
816 PRODUCT USE IN UNAPPROVED INDICATION 1151 0.0046
817 BLOOD CREATINE PHOSPHOKINASE INCREASED 133 0.0046
818 IRRITABLE BOWEL SYNDROME 99 0.0046
819 ARTHRITIS 362 0.0046
820 CIRCULATORY COLLAPSE 78 0.0046
821 HYPERHIDROSIS 590 0.0046
822 DIABETES MELLITUS 349 0.0046
823 ARTHRALGIA 1900 0.0046
824 MALIGNANT NEOPLASM PROGRESSION 466 0.0045
825 ERUCTATION 88 0.0045
826 JOINT INJURY 97 0.0045
827 CARDIOGENIC SHOCK 65 0.0045
828 EPILEPSY 138 0.0045
829 THROAT IRRITATION 201 0.0045
830 ADVERSE EVENT 410 0.0044
831 OCULAR HYPERAEMIA 211 0.0044
832 DELUSION 69 0.0044
833 NERVOUSNESS 232 0.0044
834 PANCREATITIS 234 0.0044
835 ISCHAEMIC STROKE 79 0.0044
836 SNEEZING 99 0.0044
837 SLEEP DISORDER 311 0.0044
838 DEMENTIA 123 0.0044
839 DEPRESSION 998 0.0044
840 INTENTIONAL DOSE OMISSION 125 0.0044
841 MUSCULOSKELETAL STIFFNESS 382 0.0044
842 PERICARDITIS 73 0.0043
843 FLUSHING 441 0.0043
844 PALLOR 118 0.0043
845 HYPOACUSIS 186 0.0043
846 LOCAL SWELLING 75 0.0043
847 COLON CANCER 64 0.0043
848 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 100 0.0043
849 RETCHING 91 0.0043
850 EYE IRRITATION 245 0.0043
851 COLD SWEAT 75 0.0043
852 IMPAIRED QUALITY OF LIFE 61 0.0042
853 HOT FLUSH 319 0.0042
854 BLOOD GLUCOSE ABNORMAL 78 0.0042
855 CEREBROVASCULAR ACCIDENT 713 0.0042
856 TENDONITIS 65 0.0042
857 THIRST 75 0.0042
858 RHABDOMYOLYSIS 175 0.0042
859 HAEMORRHAGE 438 0.0042
860 BLOOD PRESSURE FLUCTUATION 100 0.0042
861 HALLUCINATION, AUDITORY 66 0.0041
862 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 295 0.0041
863 PRODUCT USE COMPLAINT 65 0.0041
864 MUSCLE TWITCHING 95 0.0041
865 PULMONARY FIBROSIS 79 0.0041
866 VISUAL IMPAIRMENT 510 0.0041
867 PALPITATIONS 479 0.0041
868 JOINT STIFFNESS 107 0.0041
869 MOOD ALTERED 111 0.0041
870 ASTHMA 459 0.0041
871 LOWER LIMB FRACTURE 78 0.0041
872 TOOTH LOSS 83 0.0040
873 BLINDNESS 163 0.0040
874 DYSKINESIA 162 0.0040
875 TREATMENT NONCOMPLIANCE 218 0.0040
876 SWOLLEN TONGUE 124 0.0040
877 DISTURBANCE IN ATTENTION 212 0.0039
878 PRURITUS GENERALISED 85 0.0039
879 FREQUENT BOWEL MOVEMENTS 106 0.0039
880 ANGINA PECTORIS 112 0.0039
881 PRODUCT AVAILABILITY ISSUE 89 0.0039
882 POST PROCEDURAL COMPLICATION 75 0.0039
883 ABASIA 96 0.0039
884 HYPERSENSITIVITY 719 0.0039
885 ALOPECIA 759 0.0039
886 PRODUCT USE ISSUE 723 0.0038
887 INFLUENZA LIKE ILLNESS 316 0.0038
888 PRESCRIBED UNDERDOSE 76 0.0038
889 LIVER INJURY 92 0.0037
890 THROAT TIGHTNESS 101 0.0037
891 METASTASES TO BONE 61 0.0037
892 FRACTURE 70 0.0037
893 VISUAL ACUITY REDUCED 122 0.0037
894 GLOSSODYNIA 82 0.0037
895 MOBILITY DECREASED 263 0.0037
896 DRUG INEFFECTIVE 4804 0.0036
897 SEROTONIN SYNDROME 70 0.0036
898 ABNORMAL BEHAVIOUR 143 0.0036
899 THINKING ABNORMAL 67 0.0036
900 MIDDLE INSOMNIA 67 0.0036
901 SKIN FISSURES 70 0.0036
902 MULTIPLE SCLEROSIS RELAPSE 244 0.0036
903 EYE PRURITUS 119 0.0035
904 MIGRAINE 335 0.0035
905 THERAPY CESSATION 180 0.0035
906 INJURY 245 0.0035
907 PERITONITIS 71 0.0034
908 ILL-DEFINED DISORDER 208 0.0034
909 PAIN OF SKIN 92 0.0034
910 NEOPLASM MALIGNANT 228 0.0034
911 ANGIOEDEMA 151 0.0034
912 SURGERY 199 0.0034
913 ERECTILE DYSFUNCTION 87 0.0034
914 LACTIC ACIDOSIS 109 0.0034
915 ROAD TRAFFIC ACCIDENT 140 0.0033
916 PANIC ATTACK 121 0.0033
917 DRUG DOSE OMISSION 548 0.0033
918 CARDIOVASCULAR DISORDER 84 0.0033
919 PSYCHOTIC DISORDER 97 0.0033
920 EMOTIONAL DISORDER 101 0.0033
921 HEPATIC CIRRHOSIS 60 0.0032
922 DISCOMFORT 193 0.0032
923 TREATMENT FAILURE 262 0.0032
924 PRESCRIBED OVERDOSE 61 0.0031
925 IRRITABILITY 189 0.0031
926 PHARMACEUTICAL PRODUCT COMPLAINT 81 0.0031
927 MENTAL DISORDER 135 0.0031
928 EMOTIONAL DISTRESS 374 0.0031
929 TOXICITY TO VARIOUS AGENTS 515 0.0031
930 MOOD SWINGS 97 0.0030
931 TYPE 2 DIABETES MELLITUS 102 0.0030
932 MYOCARDIAL INFARCTION 526 0.0030
933 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 538 0.0030
934 PRODUCT PRESCRIBING ERROR 71 0.0030
935 MOVEMENT DISORDER 95 0.0030
936 ACCIDENTAL OVERDOSE 107 0.0029
937 MULTIPLE SCLEROSIS 139 0.0029
938 DEPRESSED MOOD 153 0.0029
939 ANAPHYLACTIC REACTION 159 0.0029
940 THERAPEUTIC RESPONSE UNEXPECTED 128 0.0029
941 DRUG EXPOSURE DURING PREGNANCY 97 0.0028
942 PROCEDURAL PAIN 78 0.0028
943 ECZEMA 146 0.0028
944 AGGRESSION 138 0.0028
945 BLOOD GLUCOSE INCREASED 509 0.0027
946 THERAPEUTIC RESPONSE DECREASED 163 0.0027
947 THERAPEUTIC PRODUCT EFFECT DECREASED 117 0.0026
948 HYPOGLYCAEMIA 125 0.0026
949 PREMATURE BABY 77 0.0026
950 RESPIRATORY ARREST 70 0.0025
951 NIGHTMARE 87 0.0025
952 MEDICATION ERROR 139 0.0025
953 CRYING 90 0.0025
954 EXPOSURE DURING PREGNANCY 153 0.0025
955 ABNORMAL DREAMS 66 0.0024
956 DRUG ADMINISTRATION ERROR 73 0.0024
957 VAGINAL HAEMORRHAGE 95 0.0022
958 SYSTEMIC LUPUS ERYTHEMATOSUS 76 0.0021
959 FOETAL EXPOSURE DURING PREGNANCY 173 0.0021
960 MATERNAL EXPOSURE DURING PREGNANCY 189 0.0021
961 ACNE 158 0.0021
962 SUICIDAL IDEATION 189 0.0021
963 BLOOD GLUCOSE DECREASED 96 0.0020
964 INCORRECT DOSE ADMINISTERED 441 0.0019
965 COLITIS ULCERATIVE 86 0.0019
966 ANGER 65 0.0019
967 LUNG NEOPLASM MALIGNANT 78 0.0019
968 DRUG EFFECT DECREASED 97 0.0018
969 SKIN IRRITATION 81 0.0018
970 PRODUCT SUBSTITUTION ISSUE 101 0.0018
971 SKIN BURNING SENSATION 117 0.0016
972 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 109 0.0015
973 ABORTION SPONTANEOUS 61 0.0015
974 OVERDOSE 320 0.0015
975 PRODUCT QUALITY ISSUE 201 0.0015
976 INJECTION SITE REACTION 101 0.0015
977 INJECTION SITE PRURITUS 97 0.0014
978 DERMATITIS ATOPIC 74 0.0014
979 INTENTIONAL PRODUCT MISUSE 120 0.0014
980 INJECTION SITE ERYTHEMA 167 0.0013
981 PSORIASIS 172 0.0013
982 NO ADVERSE EVENT 229 0.0013
983 RHEUMATOID ARTHRITIS 141 0.0012
984 SUICIDE ATTEMPT 70 0.0012
985 PROSTATE CANCER 92 0.0011
986 UNDERDOSE 81 0.0011
987 INJECTION SITE SWELLING 78 0.0010
988 BREAST CANCER 93 0.0010
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 197 0.0010
990 INJECTION SITE BRUISING 77 0.0010
991 COMPLETED SUICIDE 75 0.0009
992 INJECTION SITE PAIN 252 0.0008
993 DEVICE ISSUE 64 0.0007
994 DRUG WITHDRAWAL SYNDROME 62 0.0007
995 ACCIDENTAL EXPOSURE TO PRODUCT 60 0.0006